A phase II trial of AS1411 (a novel nucleolin-targeted DNA aptamer) in metastatic renal cell carcinoma-Reference-Cited by-同舟云学术

A phase II trial of AS1411 (a novel nucleolin-targeted DNA aptamer) in metastatic renal cell carcinoma

Published:2013-11-16 Issue:1 Volume:32 Page:178-187
ISSN:0167-6997
Container-title:Investigational New Drugs
language:en
Short-container-title:Invest New Drugs

Author:

Rosenberg Jonathan E.,Bambury Richard M.,Van Allen Eliezer M.,Drabkin Harry A.,Lara Primo N.,Harzstark Andrea L.,Wagle Nikhil,Figlin Robert A.,Smith Gregory W.,Garraway Levi A.,Choueiri Toni,Erlandsson Fredrik,Laber Damian A.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10637-013-0045-6.pdf

Reference28 articles.

1. Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA Cancer J Clin 62:10–29

2. Motzer RJ, Hutson TE, Tomczak P et al (2009) Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma. J Clin Oncol 27:3584–3590

3. Escudier B, Eisen T, Stadler WM et al (2007) Sorafenib in advanced clear-cell renal-cell carcinoma. N Engl J Med 356:125–134

4. Escudier B, Pluzanska A, Koralewski P et al (2007) Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial. Lancet 370:2103–2111

5. Hudes G, Carducci M, Tomczak P et al (2007) Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma. N Engl J Med 356:2271–2281

Cited by 318 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular mechanisms behind BRACO19 and human telomeric G-quadruplex interaction;Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy;2024-12

2. G-quadruplexes in long non-coding RNAs and their interactions with proteins;International Journal of Biological Macromolecules;2024-10

3. Aptamer-functionalized triptolide with release controllability as a promising targeted therapy against triple-negative breast cancer;Journal of Experimental & Clinical Cancer Research;2024-07-25

4. Aptamers: ushering in new hopes in targeted glioblastoma therapy;Journal of Drug Targeting;2024-07-03

5. Repurposing AS1411 for constructing ANM-PROTACs;Cell Chemical Biology;2024-07